John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$254M |
| 2 |
Bank of America
BAC
|
+$228M |
| 3 |
KLA
KLAC
|
+$205M |
| 4 |
TSMC
TSM
|
+$191M |
| 5 |
CVS Health
CVS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Goldman Sachs
GS
|
+$237M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
PayPal
PYPL
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.63% |
| 2 | Healthcare | 13.66% |
| 3 | Financials | 12.92% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Unifirst Corp
UNF
$5.28B
| $1.65M | ﹤0.01% |
8,291
-32,857
| -80% | -$6.06M |
|
1752
Halliburton
HAL
$28.9B
| $1.64M | ﹤0.01% |
56,597
+46,121
| +440% | +$1.45M |
|
1753
HealthStream
HSTM
$842M
| $1.64M | ﹤0.01% |
57,006
-2,171
| -4% | -$62.2K |
|
1754
Zai Lab
ZLAB
$2.88B
| $1.64M | ﹤0.01% |
68,012
+2,124
| +3% | +$40.1K |
|
1755
Beam Therapeutics
BEAM
$2.93B
| $1.64M | ﹤0.01% |
66,817
-53,948
| -45% | -$1.39M |
|
1756
Design Therapeutics
DSGN
$953M
| $1.64M | ﹤0.01% |
304,244
-98,471
| -24% | -$463K |
|
1757
Horizon Bancorp
HBNC
$1.01B
| $1.64M | ﹤0.01% |
105,215
-10,214
| -9% | -$152K |
|
1758
Forestar Group
FOR
$1.47B
| $1.64M | ﹤0.01% |
50,528
+1,167
| +2% | +$36.3K |
|
|
SII
1759
Sprott
SII
$3.49B
| $1.63M | ﹤0.01% |
37,685
+12,002
| +47% | +$508K |
|
1760
Eagle Materials
EXP
$6.27B
| $1.63M | ﹤0.01% |
5,657
-48,614
| -90% | -$12.2M |
|
|
TSE
1761
DELISTED
Trinseo
TSE
| $1.62M | ﹤0.01% |
317,910
+87,462
| +38% | +$291K |
|
|
SNV
1762
DELISTED
Synovus
SNV
| $1.62M | ﹤0.01% |
36,491
-157,717
| -81% | -$6.9M |
|
1763
Arcutis Biotherapeutics
ARQT
$3.11B
| $1.62M | ﹤0.01% |
173,665
-460,776
| -73% | -$4.55M |
|
1764
Fate Therapeutics
FATE
$292M
| $1.61M | ﹤0.01% |
459,565
-560,422
| -55% | -$2.18M |
|
1765
ADT
ADT
$5.42B
| $1.61M | ﹤0.01% |
+222,200
| New | +$1.63M |
|
1766
Fidelity Quality Factor ETF
FQAL
$1.45B
| $1.6M | ﹤0.01% |
+24,700
| New | +$1.54M |
|
1767
Janus International
JBI
$696M
| $1.59M | ﹤0.01% |
157,292
-1,137,989
| -88% | -$13.2M |
|
|
DFTX
1768
Definium Therapeutics
DFTX
$5.81B
| $1.59M | ﹤0.01% |
279,039
-404,648
| -59% | -$2.81M |
|
1769
iShares US Insurance ETF
IAK
$534M
| $1.59M | ﹤0.01% |
+12,300
| New | +$1.5M |
|
1770
Perella Weinberg Partners
PWP
$1.22B
| $1.58M | ﹤0.01% |
81,687
+3,051
| +4% | +$56K |
|
1771
American Coastal Insurance
ACIC
$441M
| $1.58M | ﹤0.01% |
139,958
+42,709
| +44% | +$477K |
|
1772
Privia Health
PRVA
$2.68B
| $1.58M | ﹤0.01% |
86,600
-37,289
| -30% | -$711K |
|
1773
Coastal Financial
CCB
$718M
| $1.58M | ﹤0.01% |
29,187
+8,183
| +39% | +$410K |
|
1774
TriCo Bancshares
TCBK
$1.74B
| $1.57M | ﹤0.01% |
36,890
-9,712
| -21% | -$419K |
|
1775
LegalZoom.com
LZ
$1.03B
| $1.57M | ﹤0.01% |
247,589
+175,042
| +241% | +$1.15M |
|
Similar funds
John Overdeck's Q3 2024 Portfolio in Review
As of Q3 2024, John Overdeck held 3,433 positions worth $45.6B, up 3.9% from $43.9B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.
John Overdeck withdrew a net $1.83B in Q3 2024, closing 348 positions and reducing 1,306 holdings. Its most notable exit was Intel, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Bank of America worth $226M.
- John Overdeck's largest Q3 2024 buy was Bank of America: 5,683,991 shares worth $226M.
- John Overdeck added most to Alphabet (Google) Class A in Q3 2024, an estimated $254M increase.
- John Overdeck's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.06B.
- John Overdeck fully exited Intel in Q3 2024, selling an estimated $161M.
- John Overdeck's ten largest holdings make up 6.6% of its $45.6B portfolio in Q3 2024.
- John Overdeck opened 444 new positions and closed 348 in Q3 2024.
- John Overdeck's portfolio value rose 3.9% quarter-over-quarter to $45.6B.
Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.